Invention Grant
- Patent Title: Triazolopyrimidine compounds and uses thereof
-
Application No.: US16863631Application Date: 2020-04-30
-
Publication No.: US11207325B2Publication Date: 2021-12-28
- Inventor: Ho Man Chan , Xiang-Ju Justin Gu , Ying Huang , Ling Li , Yuan Mi , Wei Qi , Martin Sendzik , Yongfeng Sun , Long Wang , Zhengtian Yu , Hailong Zhang , Ji Yue (Jeff) Zhang , Man Zhang , Qiong Zhang , Kehao Zhao
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agent Daniel E. Raymond
- Priority: WOPCT/CN2014/094644 20141223,WOPCT/CN2015/095320 20151123
- Main IPC: A61K31/539
- IPC: A61K31/539 ; A61K31/343 ; A61K31/5377 ; A61K31/541 ; A61K31/551 ; C07D487/04 ; A61K31/519 ; A61K45/06
Abstract:
A compound of Formula (I), or a pharmaceutically acceptable salt thereof, is provided that has been shown to be useful for treating a PRC2-mediated disease or disorder: wherein R1, R2, R3, R4, R5, and n are as defined herein.
Public/Granted literature
- US20200323859A1 TRIAZOLOPYRIMIDINE COMPOUNDS AND USES THEREOF Public/Granted day:2020-10-15
Information query
IPC分类:
